Literature DB >> 32272208

Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M Pavel1, K Öberg2, M Falconi3, E P Krenning4, A Sundin5, A Perren6, A Berruti7.   

Abstract

Entities:  

Keywords:  Clinical Practice Guidelines; GEP-NENs; GEP-NETs; Pan-NENs; SI-NETs; diagnosis; gastroenteropancreatic neuroendocrine neoplasms; treatment and follow-up

Mesh：

Substances：

Year:  2020        PMID： 32272208     DOI： 10.1016/j.annonc.2020.03.304

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  131 in total

1.  ASO Author Reflections: A Genomic Blood Test (NETest) that Informs you if the Patient has a Recurrence at the First Postoperative Visit.

Authors:  Irvin M Modlin
Journal:  Ann Surg Oncol       Date:  2021-04-19       Impact factor: 5.344

2.  Immunotherapeutics at the spearhead: current status in targeting neuroendocrine neoplasms.

Authors:  Anna Koumarianou; Gregory A Kaltsas; Eleftherios Chatzellis; Georgios Kyriakopoulos; Denise Kolomodi; Krystallenia I Alexandraki
Journal:  Endocrine       Date:  2021-02-05       Impact factor: 3.633

3.  Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest).

Authors:  Irvin M Modlin; Mark Kidd; Kjell Oberg; Massimo Falconi; Pier Luigi Filosso; Andrea Frilling; Anna Malczewska; Ronald Salem; Christos Toumpanakis; Faidon-Marios Laskaratos; Stefano Partelli; Matteo Roffinella; Claudia von Arx; Beata Kos Kudla; Lisa Bodei; Ignat A Drozdov; Alexandra Kitz
Journal:  Ann Surg Oncol       Date:  2021-05-18       Impact factor: 5.344

4.  Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study.

Authors:  Dieter Hörsch; Lowell Anthony; David J Gross; Juan W Valle; Staffan Welin; Marta Benavent; Martyn Caplin; Marianne Pavel; Emily Bergsland; Kjell Öberg; Kenneth B Kassler-Taub; Polina Binder; Phillip Banks; Pablo Lapuerta; Matthew H Kulke
Journal:  Neuroendocrinology       Date:  2021-05-03       Impact factor: 4.914

Review 5.  Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.

Authors:  Valentina Ambrosini; Jolanta Kunikowska; Eric Baudin; Lisa Bodei; Catherine Bouvier; Jaume Capdevila; Marta Cremonesi; Wouter W de Herder; Clarisse Dromain; Massimo Falconi; Melpomeni Fani; Stefano Fanti; Rodney J Hicks; Levent Kabasakal; Gregory Kaltsas; Val Lewington; Silvia Minozzi; Michela Cinquini; Kjell Öberg; Wim J G Oyen; Dermot O'Toole; Marianne Pavel; Philippe Ruszniewski; Aldo Scarpa; Jonathan Strosberg; Anders Sundin; David Taïeb; Irene Virgolini; Damian Wild; Ken Herrmann; James Yao
Journal:  Eur J Cancer       Date:  2021-02-12       Impact factor: 9.162

6.  Rare Presentation of a Metastatic Pancreatic Neuroendocrine Neoplasm Presenting with Atrial Flutter.

Authors:  Paraskevi C Fragkou; Ioannis A Papadopoulos; Antonios Papadopoulos; Evangelos-Achilleas Kontoveros; Gregory Kaltsas; Foula Vassilara
Journal:  Eur J Case Rep Intern Med       Date:  2021-01-20

7.  Perspectives on the current pharmacotherapeutic strategies for management of functional neuroendocrine tumor syndromes.

Authors:  Tetsuhide Ito; Robert T Jensen
Journal:  Expert Opin Pharmacother       Date:  2020-11-11       Impact factor: 3.889

8.  Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs).

Authors:  Alberto Puccini; Kelsey Poorman; Mohamed E Salem; Davide Soldato; Andreas Seeber; Richard M Goldberg; Anthony F Shields; Joanne Xiu; Francesca Battaglin; Martin D Berger; Ryuma Tokunaga; Madiha Naseem; Afsaneh Barzi; Syma Iqbal; Wu Zhang; Shivani Soni; Jimmy J Hwang; Philip A Philip; Stefania Sciallero; W Michael Korn; John L Marshall; Heinz-Josef Lenz
Journal:  Clin Cancer Res       Date:  2020-09-03       Impact factor: 12.531

Review 9.  Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials.

Authors:  E Panagiotou; G Gomatou; I P Trontzas; N Syrigos; E Kotteas
Journal:  Clin Transl Oncol       Date:  2021-08-07       Impact factor: 3.405

Review 10.  Liver-Directed Therapies for Neuroendocrine Neoplasms.

Authors:  Ashley Kieran Clift; Andrea Frilling
Journal:  Curr Oncol Rep       Date:  2021-03-15       Impact factor: 5.075
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.